Back to Search
Start Over
Update of the M.D. Anderson Cancer Center experience with hyper-CVAD and rituximab for the treatment of mantle cell and Burkitt-type lymphomas.
- Source :
- Clinical Lymphoma & Myeloma; Dec2007 Supplement 2, Vol. 8, pS57-62, 1p
- Publication Year :
- 2007
Details
- Language :
- English
- ISSN :
- 15579190
- Volume :
- 8
- Database :
- Complementary Index
- Journal :
- Clinical Lymphoma & Myeloma
- Publication Type :
- Academic Journal
- Accession number :
- 105722507